补肾促卵方对6种疾病所致排卵障碍性不孕女性的效果:一项随机双盲阳性对照适应性多中心临床试验的研究方案
本研究为随机双盲双模拟阳性对照适应性多中心临床试验,纳入6种疾病所致排卵障碍性不孕女性,按1:1随机分为补肾促卵方组与枸橼酸氯米芬组,主要比较妊娠率并识别补肾促卵方疗效更优的排卵障碍疾病类型。
要点
- 补肾促卵方组:补肾促卵方13g每日三次连用14天,加枸橼酸氯米芬安慰剂50mg每日一次从每个月经周期第5天起连用5天。
- 对照组:补肾促卵方安慰剂13g每日三次连用14天,加枸橼酸氯米芬50mg每日一次从每个月经周期第5天起连用5天。
- 全疗程持续3个或6个月经周期,取决于前3个月经周期是否恢复排卵。
核心结论
- 本随机对照试验旨在评估补肾促卵方能否使排卵障碍性不孕女性获得比枸橼酸氯米芬更高的妊娠率,并识别补肾促卵方疗效更高的排卵障碍疾病类型。
研究设计与样本
- 随机、双盲、双模拟、平行、阳性对照、适应性、多中心临床试验。
- 参与者通过中央随机化系统按1:1比例随机分配至治疗组或对照组。
- 研究纳入6种疾病所致排卵障碍性不孕:排卵障碍性异常子宫出血、多囊卵巢综合征、高催乳素血症、黄素化未破裂卵泡综合征、黄体功能不足和早发性卵巢功能不全。
主要发现
- 原文为研究方案,未报告研究结果。
关键数值与推荐
- 治疗组:补肾促卵方13g每日三次连用14天,加枸橼酸氯米芬安慰剂片50mg每日一次从每个月经周期第5天起连用5天。
- 对照组:补肾促卵方安慰剂13g每日三次连用14天,加枸橼酸氯米芬片50mg每日一次从每个月经周期第5天起连用5天。
- 全疗程持续3个或6个月经周期,取决于前3个月经周期是否恢复排卵。
- 所有统计分析在SPSS 21.0中进行,p值<0.05视为有统计学意义。
临床怎么用
- 原文未据此给出临床推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Anovulation is one of the main causes of female infertility. This study will evaluate the effectiveness and safety of Bushen Culuan Decoction for anovulatory infertility caused by six diseases, including anovulatory abnormal uterine bleeding, polycystic ovarian syndrome, hyperprolactinemia, luteinized unruptured follicle syndrome, corpus luteum insufficiency, and premature ovarian insufficiency. METHODS: This is a randomized, double-blinded, double-dummy, parallel, positively controlled, adaptive, multicenter clinical trial. All participants will be randomly allocated by a central randomization system to the treatment group or the control group in a 1:1 ratio. The treatment group will undergo a 14-day treatment with Bushen Culuan Decoction 13 g three times a day and a 5-day treatment with clomiphene citrate placebo tablets 50 mg once a day starting on day 5 of every menstrual period. The control group will undergo a 14-day treatment with Bushen Culuan Decoction placebo 13 g three times a day and a 5-day treatment with clomiphene citrate tablets 50 mg once a day from day 5 in every menstrual period. The whole treatment will last through 3 menstrual periods or 6 menstrual periods, depending on whether ovulation is regained in the first 3 menstrual periods. All statistical analyses will be performed in SPSS 21.0 (SPSS, Chicago, Illinois, USA), and a p value < 0.05 will be considered statistically significant. DISCUSSION: The objective of this RCT is to evaluate whether Bushen Culuan Decoction enables a higher pregnancy rate than clomiphene citrate in women with anovulatory infertility and to identify the anovulatory diseases for which Bushen Culuan Decoction has higher effectiveness .This study has been approved by the Medical Ethics Committee of Xiyuan Hospital China Academy of Chinese Medical Sciences (No. 2017XLA037-2). The results of this study will be offered for publication in peer-reviewed journals. TRIAL REGISTRATION: ClinicalTrials.gov NCT03709849 . Registered on 19 November 2018.
引用
- Ma K, Shi Y, He J, et al. The effect of Bushen Culuan Decoction on anovulatory infertile women among 6 different diseases: a study protocol for a randomized, double-blinded, positively controlled, adaptive multicenter clinical trial. Trials. 2022. PMID: 35804385. doi:10.1186/s13063-022-06289-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。